Group Schema Therapy for the Other Specified Personality Disorder: a pilot study.
- Conditions
- Other Specified Personality Disorder
- Registration Number
- NL-OMON20495
- Lead Sponsor
- niversiteit van Amsterdam and PsyQ Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Patients with Other Specified PD based on the DSM-5 as primary diagnosis (assessed with SCID-5-P).
- Age 18-70
- Ability to understand, read, write and speak Dutch.
- DSM-5 alcohol or drug dependence. (After 3 months of abstinence participation is possible).
- Comorbid psychotic disorder
- DSM-5 Bipolar disorder, type 1 (current or past)
- (Sub)threshold Borderline PD
- Acute suicide risk
- IQ<80
- Schema Therapy of any kind (e.g., individual, group, inpatient, outpatient, day treatment) in the past year.
- patients should not start with any form of psychological treatment or medication during screening or during the study’s treatment or waitlist period. Medication should be on a stable level for 3 months, if not stopped. (Non-PD focused supportive treatment may be continued during wait and screening, but not during the study treatment and study 1-year follow-up period)
- Not able to plan (group) therapy sessions of 90 minutes within the treatment period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main outcome variable is change in severity of manifestations of OSPD, measured with ADP-IV (Schotte & De Donker, 1996)
- Secondary Outcome Measures
Name Time Method